$250 | Single User
$500 | Site License
$750 | Global License

Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 11-07-2018]

Published by Global Data: 11 Jul 2018 | 213045 | In Stock

Introduction

Summary

Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurposing, patient selection, drug combinations, pathway elucidation, new indications, indication selection and companion diagnostic programs. MPI also offers drug specific interface to the human genome and predict drug response in individual patients. The company has partnerships with various cancer drug developing companies. It operates in Denmark and the US. MPI is headquartered in Horsholm, Denmark.

Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 11-07-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Medical Prognosis Institute A/S, Medical Devices Deals, 2012 to YTD 2018 9

    Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

    Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deal Details 11

    Venture Financing 11

    Oncology Venture Raises USD0.56 Million in Venture Financing 11

    Partnerships 12

    Medical Prognosis Institute Enters into Co-Development Agreement with Alion Pharma 12

    Merger 13

    Oncology Venture to Merger with Medical Prognosis Institute 13

    Licensing Agreements 14

    Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 14

    Asset Transactions 15

    Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 15

    Medical Prognosis Institute A/S - Key Competitors 16

    Medical Prognosis Institute A/S - Key Employees 17

    Medical Prognosis Institute A/S - Locations And Subsidiaries 18

    Head Office 18

    Other Locations & Subsidiaries 18

    Recent Developments 19

    Financial Announcements 19

    Mar 23, 2018: MPI publishes Annual report for 2017 19

    Mar 13, 2018: Medical Prognosis Institute publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture 22

    Aug 31, 2017: MPI publishes Half-year Report for the first half of 2017 23

    Corporate Communications 25

    May 31, 2018: MPI - Change in Board of directors 25

    Other Significant Developments 26

    Jul 02, 2018: Oncology Venture Sweden: Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients Collaborative LiPlaCis Regulatory Meeting with DKMA 26

    Jul 02, 2018: MPI - Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients - Collaborative LiPlaCis Regulatory Meeting with DKMA 29

    Appendix 32

    Methodology 32

    About GlobalData 32

    Contact Us 32

    Disclaimer 32

List Of Tables
in Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 11-07-2018]

List of Tables

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical Prognosis Institute A/S, Deals By Therapy Area, 2012 to YTD 2018 8

Medical Prognosis Institute A/S, Medical Devices Deals, 2012 to YTD 2018 9

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Oncology Venture Raises USD0.56 Million in Venture Financing 11

Medical Prognosis Institute Enters into Co-Development Agreement with Alion Pharma 12

Oncology Venture to Merger with Medical Prognosis Institute 13

Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 14

Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 15

Medical Prognosis Institute A/S, Key Competitors 16

Medical Prognosis Institute A/S, Key Employees 17

Medical Prognosis Institute A/S, Subsidiaries 18

List Of Figures, Charts and Diagrams
in Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 11-07-2018]

List of Figures

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medical Prognosis Institute A/S, Medical Devices Deals, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

213045 | GDPH110071D

Number of Pages

32

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Building Strong Cross-Functional Medical Affairs Teams
IntroductionCould your Medical Affairs team be better integrated for more effective cross-functional...
01 May 2015 by FirstWord Pharma USD $695 More Info
Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders
IntroductionBased on survey results from 150 rheumatologists, dermatologists, and gastroenterologist...
01 Feb 2015 by FirstWord Pharma USD $5,995 More Info
Physician Views: How do endocrinologists value diabetes-focused medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
08 Dec 2014 by FirstWord Pharma USD $695 More Info
Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies
IntroductionAs the cancer drug market continues to face significant challenges in an environment of ...
02 Dec 2014 by FirstWord Pharma USD $3,900 More Info
Reshaping Medical Affairs: delivering value to KOLs and payers
IntroductionHistorically, the key role of Medical Affairs was supporting the initial regulatory appr...
21 Aug 2014 by FirstWord Pharma USD $695 More Info
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
IntroductionAs the oncology drug market continues to face significant road bumps in terms of develop...
14 Aug 2014 by FirstWord Pharma USD $3,900 More Info
Physician Views: How do pulmonologists value medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
09 Jul 2014 by FirstWord Pharma USD $695 More Info
Physician Views: How do neurologists value multiple sclerosis medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
18 Jun 2014 by FirstWord Pharma USD $695 More Info
Physician Views: How do oncologists value medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
22 May 2014 by FirstWord Pharma USD $695 More Info
Ensuring Optimal Medical Affairs Performance: Delivering Measurable Value
IntroductionIn this era of transparency, Medical Affairs is rapidly becoming the new voice of Pharma...
01 May 2013 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 11-07-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data